Achalasia: a new clinically relevant classification by high-resolution manometry
John E Pandolfino, Monika A Kwiatek, Thomas Nealis, William Bulsiewicz, Jennifer Post, Peter J Kahrilas, John E Pandolfino, Monika A Kwiatek, Thomas Nealis, William Bulsiewicz, Jennifer Post, Peter J Kahrilas
Abstract
Background & aims: Although the diagnosis of achalasia hinges on demonstrating impaired esophagogastric junction (EGJ) relaxation and aperistalsis, 3 distinct patterns of aperistalsis are discernable with high-resolution manometry (HRM). This study aimed to compare the clinical characteristics and treatment response of these 3 subtypes.
Methods: One thousand clinical HRM studies were reviewed, and 213 patients with impaired EGJ relaxation were identified. These were categorized into 4 groups: achalasia with minimal esophageal pressurization (type I, classic), achalasia with esophageal compression (type II), achalasia with spasm (type III), and functional obstruction with some preserved peristalsis. Clinical and manometric variables including treatment response were compared among the 3 achalasia subtypes. Logistic regression analysis was performed using treatment success as the dichotomous dependent variable controlling for independent manometric and clinical variables.
Results: Ninety-nine patients were newly diagnosed with achalasia (21 type I, 49 type II, 29 type III), and 83 of these had sufficient follow-up to analyze treatment response. Type II patients were significantly more likely to respond to any therapy (BoTox [71%], pneumatic dilation [91%], or Heller myotomy [100%]) than type I (56% overall) or type III (29% overall) patients. Logistic regression analysis found type II to be a predictor of positive treatment response, whereas type III and pretreatment esophageal dilatation were predictive of negative treatment response.
Conclusions: Achalasia can be categorized into 3 subtypes that are distinct in terms of their responsiveness to medical or surgical therapies. Utilizing these subclassifications would likely strengthen future prospective studies of treatment efficacy in achalasia.
Conflict of interest statement
Conflict of interests: John Pandolfino (consultant: Astra Zeneca, Santarus, Medtronic, Crospon, TAP; speaker: Astra Zeneca, Santarus, Medtronic); Monika Kwiatek (none), Thomas Nealis (none), William Bulsiewicz (none), Jennifer Post (none), and Peter J. Kahrilas (none). Other conflicts of interest were not disclosed because this was a retrospective analysis of medical records and manometry studies.
Figures
References
- Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut. 2001;49:145–151.
- Pandolfino JE, Kahrilas PJ. AGA technical review on the clinical use of esophageal manometry. Gastroenterology. 2005;128:209–224.
- Goldenberg SP, Burrell M, Fette GG, et al. Classic and vigorous achalasia: a comparison of manometric, radiographic, and clinical findings. Gastroenterology. 1991;101:743–748.
- Todorczuk JR, Aliperti G, Staiano A, et al. Reevaluation of manometric criteria for vigorous achalasia. Is this a distinct clinical disorder? Dig Dis Sci. 1991;36:274–278.
- Hirano I, Tatum RP, Shi G, et al. Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology. 2001;120:789–798.
- Csendes A, Braghetto I, Henriquez A, et al. Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut. 1989;30:299–304.
- Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology. 1996;110:1410–1415.
- Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut. 1999;44:231–239.
- Annese V, Bassotti G, Coccia G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut. 2000;46:597–600.
- Mikaeli J, Fazel A, Montazeri G, et al. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther. 2001;15:1389–1396.
- Bansal R, Nostrant TT, Scheiman JM, et al. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol. 2003;36:209–214.
- Bonatti H, Hinder RA, Klocker J, et al. Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia. Am J Surg. 2005;190:874–878.
- Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006;4:580–587.
- Gockel I, Junginger T, Eckardt VF. Long-term results of conventional myotomy in patients with achalasia: a prospective 20-year analysis. J Gastrointest Surg. 2006;10:1400–1408.
- Sanderson DR, Ellis FH, Jr, Schlegel JF, et al. Syndrome of vigorous achalasia: clinical and physiologic observations. Dis Chest. 1967;52:508–517.
- Bondi JL, Godwin DH, Garrett JM. “Vigorous” achalasia. Its clinical interpretation and significance. Am J Gastroenterol. 1972;58:145–155.
- Camacho-Lobato L, Katz PO, Eveland J, et al. Vigorous achalasia: original description requires minor change. J Clin Gastroenterol. 2001;33:375–377.
- Fox M, Hebbard G, Janiak P, et al. High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil. 2004;16:533–542.
- Pandolfino JE, Ghosh SK, Rice J, et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol. 2008;103:27–37.
- Ghosh SK, Pandolfino JE, Rice J, et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol. 2007;293:G878–G885.
- Pandolfino JE, Ghosh SK, Zhang Q, et al. Quantifying EGJ morphology and relaxation with high-resolution manometry: a study of 75 asymptomatic volunteers. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1033–1040.
- Staiano A, Clouse RE. Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors. Am J Gastroenterol. 2001;96:3258–3267.
Source: PubMed